OneMedNet Corporation Announces Record Bookings and Dramatic Improvements in Data Fulfillment

OneMedNet Corporation (Nasdaq: ONMD), a provider of clinical imaging solutions and real‑world data (RWD) for life‑science and medical‑device organizations, released a third‑quarter earnings update on 18 September 2026 that underscores a significant acceleration in both sales momentum and operational capability.

Record Bookings Surpass Expectations

  • Year‑to‑date 2026 bookings: approximately $16.2 million, a 16‑fold increase compared with the same period in 2025.
  • The bookings figure comprises multi‑modal datasets, datasets‑plus‑license arrangements, and multi‑year platform access licenses.
  • Roughly 50 % of the 2026 contracts come from new customers, while the remainder represent reorders and follow‑on engagements from an expanding existing client base.

These numbers illustrate a strong demand for OneMedNet’s iRWD™ Platform, which delivers fit‑for‑purpose RWD to support regulatory submissions, AI model development, cohort discovery, feasibility studies, and high‑value research.

Operational Gains: 50‑Times Faster Order Fulfillment

Platform upgrades have increased order‑fulfillment speed by an estimated 50×, allowing the company to assemble, qualify, and deliver large orders more rapidly. This improvement is expected to enable OneMedNet to meet stringent project timelines for life‑science, medical‑device, and AI customers, thereby reinforcing its competitive position in the market.

Strategic Growth Highlights

  • New customer acquisition: The 2026 contracts include a significant share from first‑time clients, signaling expanding market reach.
  • Existing customer expansion: High reorder rates and follow‑on engagements from current clients suggest strong satisfaction and reliance on OneMedNet’s services.
  • AI‑driven data offerings: The company secured an agreement valued at over $11.5 million for foundational AI model data, reinforcing its role as a leading source of high‑quality RWD for AI development.

Financial Snapshot

  • Close price (16 September 2026): $0.611 per share.
  • 52‑week high (9 October 2025): $4.22.
  • 52‑week low (16 June 2026): $0.49.
  • Market capitalization: $36,480,000.
  • Price‑to‑earnings ratio: –4.02 (negative due to the company’s current loss position).

Despite a modest free‑cash‑flow position—$358,000 in cash as of 30 June 2026—the announcement of record bookings signals a robust pipeline of future revenue. The market reaction has been mixed; however, the 16‑fold increase in bookings provides a clear indicator of growth potential and operational efficiency.

Outlook

OneMedNet’s continued focus on enhancing platform speed and expanding its customer base positions the company to capitalize on the growing demand for real‑world data in regulatory and AI contexts. The combination of rapid fulfillment, high‑value contracts, and a sizable backlog suggests that OneMedNet is poised to convert its booking momentum into tangible revenue growth in the coming quarters.